GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at ScaleBusiness Wire • 05/22/25
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 04/30/25
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?Zacks Investment Research • 04/21/25
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global ScaleBusiness Wire • 04/16/25
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025Business Wire • 04/08/25
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New IndicationBusiness Wire • 04/03/25
Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff ThreatsZacks Investment Research • 04/02/25
Fast Company Recognizes GeneDx as One of the World's Most Innovative CompaniesBusiness Wire • 03/18/25
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual MeetingBusiness Wire • 03/13/25
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical AnalysisBusiness Wire • 03/13/25
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New IndicationBusiness Wire • 03/04/25